MHRA unveils roadmap for new medical device regulations in the UK

Share this article Along with Fusion’s pipeline of radioconjugates, AstraZeneca said the deal will bring new research and development (R&D) expertise and supply chain strengthening.

US reg­u­la­tors want to see more ef­fi­ca­cy da­ta be­fore they con­sid­er ap­prov­ing Sanofi and Re­gen­eron’s Dupix­ent in a skin con­di­tion char­ac­ter­ized by chron­ic hives, Sanofi

The FDA on Mon­day pub­lished an­oth­er draft guid­ance on drug com­pa­nies’ com­mu­ni­ca­tions with health­care providers re­gard­ing the un­ap­proved use of ap­proved med­ical prod­ucts. The 29-page